Business Wire

Takeda Presents Orexin Data from Landmark Oveporexton (TAK-861) Phase 3 Program in Narcolepsy Type 1 at World Sleep 2025

SINGAPORE & OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) will present data from two global Phase 3 double-blind, placebo-controlled studies of oveporexton (TAK-861) 1, ...
Benzinga.com

Moderna Stops CMV Program As Vaccine Falls Short In Preventing Infection

Moderna, Inc. (NASDAQ:MRNA) revealed topline results on Wednesday from a Phase 3 trial evaluating the efficacy of mRNA-1647, the company’s investigational cytomegalovirus (CMV) vaccine. CMV is a ...
Travel Weekly

JetBlue and United implement first phase of Blue Sky partnership

United and JetBlue loyalty program members can now earn and redeem point across the two airlines. Loyalty program reciprocity is the first implementation of the airlines' Blue Sky partnership, which ...
C&EN

Single Crystals of Vanadium Oxides as a Lens for Understanding Structural and Electronic Phase Transformations, Ion Transport, Chemo-Mechanical Coupling, and Electrothermal ...

Department of Chemistry, Texas A&M University, College Station, Texas 77843, United States Department of Materials Science and Engineering, Texas A&M University, College Station, Texas 77843, United ...
Seeking Alpha

Arcturus Therapeutics Provides Interim Phase 2 Data for Cystic Fibrosis (CF) Program

After only 28 days of treatment with ARCT-032 (10 mg), 4 out of 6 Class I CF participants exhibited encouraging reduction of mucus plug number and mucus volume 12-week study enrolling up to 20 CF ...
FierceBiotech

Terns mothballs obesity program after phase 2 data fall short

Terns Pharmaceuticals has shelved its oral GLP-1 obesity candidate after a phase 2 trial delivered a mix of weight loss and tolerability data that fell short of expectations as well as evidence the ...
Mass Transit

Santa Clara VTA confirms single bore as preferred tunnel configuration for BART Silicon Valley Phase II Project

The Santa Clara Valley Transportation Authority (VTA) has confirmed the large single bore as the preferred tunnel configuration for the Bay Area Rapid Transit (BART) Silicon Valley Phase II Project ...
FierceBiotech

Neuphoria nixes social anxiety program and starts strategic review after phase 3 flop

Neuphoria Therapeutics’ lead candidate has failed to improve social anxiety symptoms in a late-stage trial, prompting the biotech to discontinue the program and launch a strategic review of its ...
BioSpace

Summit Therapeutics Announces Expansion of Ivonescimab Global Phase III Development Program with HARMONi-GI3 Study in 1L Colorectal Cancer

MIAMI--(BUSINESS WIRE)--$SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced the expansion of its Phase III clinical ...
BioSpace

Marengo Presents Initial Phase 2 Results Demonstrating Broad Single-Agent Activity of Invikafusp Alfa Across Multiple PD-1-Refractory or -Resistant Solid Tumors as a Late ...

20.5% ORR and 79% DCR observed in heavily pretreated TMB-H or MSI-H/dMMR tumors across six major solid tumor types, including colorectal, lung, breast, gastric, GEJ, and head and neck cancers 52% of ...
ahajournals.org

Association of Component Strategies of the Target Stroke Phase 3 Nationwide Quality Improvement Program With Accelerated Door-to-Puncture and Door-In-Door-Out Times for ...

The Target Stroke Phase III program is a national quality improvement initiative led by the American Heart Association, which sought to improve the quality of care for patients with acute stroke ...